Microcoaxial phaco better than standard phaco

Article

Microcoaxial phacoemulsification induces significantly less keratometric changes and provides better visual acuity than standard phacoemulsification.

Microcoaxial phacoemulsification induces significantly less keratometric changes and provides better visual acuity than standard phacoemulsification, according to Seyed Javad Hashemian and colleagues from the Fajr Hospital & Negah Eye Hospital, Tehran, Iran.

In a controlled prospective clinical trial, 69 eyes of subjects with senile cataract (grade 3 to 4 on the Lens opacities Classification System III) underwent phacoemulsification. The subjects were randomized to undergo either microcoaxial phaco (39 eyes; Sovereign WhiteStar; AMO) or conventional phaco (30 eyes; Legacy 20000, Everest; Alcon). In each case, the incision was made into a temporarily clear cornea and a hydrophobic acrylic flexible intraocular lens (Acrysof Natural, SN60AT; Alcon) was implanted.

The researchers found that the only statistically significant difference between the two groups was the surgically induced keratometric changes at five days postoperatively. (p=0.02).

At the study's conclusion, Dr Hashemian an colleagues concluded that, although both techniques were safe and effective for cataract surgery, microcoaxial phacoemulsification induced significantly less surgical keratometric changes and yielded better visual acuity in the early postoperative days.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.